BMY · Bristol Myers Squibb Co
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2023-12-01 | — | $5,000,000,000 | 2026-03-31 | — | 10-Q , filed 2026-04-30 |
Cash spent on buybacks by quarter
Cash deployed each quarter, with the average price paid where the company reported it. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $0 | 10-K, filed 2026-02-11 |
| 2024-12-31 | $0 | 10-K, filed 2026-02-11 |
| 2023-12-31 | $5,155,000,000 | 10-K, filed 2026-02-11 |
| 2022-12-31 | $8,001,000,000 | 10-K, filed 2025-02-12 |
| 2021-12-31 | $6,287,000,000 | 10-K, filed 2024-02-13 |
| 2020-12-31 | $1,546,000,000 | 10-K, filed 2023-02-14 |
| 2019-12-31 | $7,300,000,000 | 10-K, filed 2022-02-09 |
| 2018-12-31 | $320,000,000 | 10-K, filed 2021-02-10 |
| 2017-12-31 | $2,469,000,000 | 10-K, filed 2020-02-24 |
| 2016-12-31 | $231,000,000 | 10-K, filed 2019-02-25 |
| 2013-12-31 | $433,000,000 | 10-K, filed 2016-02-12 |
| 2012-12-31 | $2,403,000,000 | 10-K, filed 2015-02-13 |
| 2011-12-31 | $1,221,000,000 | 10-K, filed 2014-02-14 |
| 2010-12-31 | $576,000,000 | 10-K, filed 2013-02-15 |